Clinical Trial Update: Bupivacaine Liposome Serrate Anterior Plane Block vs Traditional Thoracic Paravertebral Block [NA]

View source ↗

Summary

A clinical trial comparing liposomal bupivacaine serratus anterior plane block to thoracic paravertebral block for lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Exparel (liposomal bupivacaine) (liposomal bupivacaine)

Snippet

Sponsor: Shiyou Wei | Conditions: Lung Cancer | NA | Status: WITHDRAWN